These Nanoparticles are Promising Candidates for Sustained Breast Cancer Drug Delivery

Anastrozole (ANS) anticancer therapy needs long-term administration until tumor regression is achieved. In an article recently published in the journal Materials Today, researchers explored anastrozole-loaded silk fibroin nanoparticles as promising candidates for sustained drug delivery in breast cancer treatment.